THE EFFECT OF AROMATHERAPY FOOT BATHS ON CANCER PATIENTS

The goal of this randomised clinical trial is to evaluate the effects of aromatherapy-infused foot baths on pain, sleep quality, and fatigue in cancer patients. The main question[s] it aims to answer are:

* Is an aromatherapy foot bath effective in reducing pain in cancer patients? * Is an aromatherapy foot bath effective in improving sleep quality in cancer patients? * Is an aromatherapy foot bath effective in reducing fatigue in cancer patients? The experimental group will receive a total of 5 sessions of aromatherapy foot baths, each lasting 20 minutes per day for 5 days, administered by the researcher. The control group will receive only routine care without any treatment. Before and after all treatments are completed, participants will be given and asked to complete the Hirai Cancer Fatigue Scale, the Pittsburgh Sleep Quality Index (PSQI), and the Numerical Pain Scale. The pain, fatigue, and sleep quality scores of the experimental and control groups will then be compared.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Patients Diagnosed With Cancer Dyssomnias Fatigue Mental Disorders Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients over 18 years of age,
Conscious (Glasgow coma scale: 15 points)
No diagnosis of mental illness
No respiratory distress
No diagnosis of respiratory system disorder
Patients who agree to participate in the study

Exclusion criteria

Patients under 18 years of age,
Patients with a Glasgow Coma Scale score below 15 points,
Patients with a diagnosis of mental illness,
Patients with respiratory distress,
Patients with a diagnosis of respiratory system disease,
Patients with hemiplegia or paraplegia,
Patients who refused to participate in the study.

Treatment and study plan

Aromatherapy

Other

The experimental group will receive a foot bath treatment containing aromatherapy for 5 days administered by the researcher. A foot bath device will be used. Lavender essential oil will be added to the water as aromatherapy. Then, the researcher will administer a foot bath to the patient using this water.

Primary outcomes

Hirai Cancer Fatigue Scale

Time frame: Baseline and day 5

The scale has a minimum score of 15 and a maximum score of 75. Higher scores indicate increased fatigue, while lower scores indicate decreased fatigue.
Numerical Pain Scale

Time frame: Baseline and day 5

Participants will be asked to rate the intensity of their pain on a scale of 0 (no pain) to 10 (most severe pain). A higher score indicates increasing pain.
Pittsburgh Sleep Quality Index

Time frame: Baseline and day 5

The total score ranges from 0 to 21. A total score higher than 5 indicates poor sleep quality.

Study contacts

Contact information is provided by the study sponsor or research team.

Erdal Ceylan

CONTACT

[email protected]

+905362323599

Sponsors and collaborators

Lead sponsor

Ankara Yildirim Beyazıt University

Other

Registry information

Official study title

THE EFFECT OF AROMATHERAPY FOOT BATHS ON PAIN, SLEEP QUALITY, AND FATIGUE IN CANCER PATIENTS: A RANDOMIZED CONTROLLED TRIAL

Acronym: AROMA-FOOTBATH

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Jul 22, 2026
Registry last updated: Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting